Altogether, it seems that a subset of insulin signaling effects – including those related to androgen production – tend to remain insulin-responsive with PCOS, despite the potential for reduced insulin sensitivity with respect to some metabolic processes. This evidence concerns the gene INS and polycystic ovary syndrome.